Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
3301
DELISTED
Brookline Bancorp
BRKL
| $3.34M | ﹤0.01% |
218,907
+61,964
| +39% | +$899K |
|
|
ARBK
3302
Argo Blockchain
ARBK
$41.9M
| $3.34M | ﹤0.01% |
+966
| New | +$3.38M |
|
|
HLMNW
3303
CALL
DELISTED
Hillman Solutions Corp. Warrant
HLMNW
| $3.34M | ﹤0.01% |
1,151,666
+225,000
| +24% | +$684K |
|
3304
UBS Group
UBS
$173B
| $3.33M | ﹤0.01% |
209,214
-511,045
| -71% | -$8.28M |
|
3305
AerCap
AER
$23.7B
| $3.33M | ﹤0.01% |
57,581
+47,967
| +499% | +$2.57M |
|
3306
Regency Centers
REG
$14.7B
| $3.32M | ﹤0.01% |
49,358
-201,964
| -80% | -$13.4M |
|
|
DHHCU
3307
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
| $3.31M | ﹤0.01% |
334,001
-466,768
| -58% | -$4.63M |
|
3308
Idacorp
IDA
$8.27B
| $3.29M | ﹤0.01% |
31,850
+19,016
| +148% | +$1.99M |
|
|
FRSG
3309
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
| $3.29M | ﹤0.01% |
334,668
-339,373
| -50% | -$3.32M |
|
3310
Assurant
AIZ
$13.8B
| $3.29M | ﹤0.01% |
20,855
-5,382
| -21% | -$869K |
|
|
SAND
3311
DELISTED
Sandstorm Gold
SAND
| $3.29M | ﹤0.01% |
+570,666
| New | +$3.94M |
|
3312
Grupo Aeroportuario Centro Norte
OMAB
$5.16B
| $3.29M | ﹤0.01% |
+70,111
| New | +$3.4M |
|
3313
NMI Holdings
NMIH
$3.33B
| $3.28M | ﹤0.01% |
145,071
-273,133
| -65% | -$6.01M |
|
|
SEE
3314
DELISTED
Sealed Air
SEE
| $3.27M | ﹤0.01% |
59,728
+34,500
| +137% | +$2M |
|
|
HCII
3315
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
| $3.27M | ﹤0.01% |
335,370
+83,428
| +33% | +$812K |
|
3316
CarMax
KMX
$8.13B
| $3.27M | ﹤0.01% |
25,526
-29,495
| -54% | -$3.93M |
|
|
NRAC
3317
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
| $3.26M | ﹤0.01% |
336,088
+194,994
| +138% | +$1.89M |
|
3318
ResMed
RMD
$30.6B
| $3.26M | ﹤0.01% |
12,373
-193,308
| -94% | -$52.9M |
|
|
AMPI.U
3319
DELISTED
Advanced Merger Partners Inc Units
AMPI.U
| $3.26M | ﹤0.01% |
330,142
-93,664
| -22% | -$926K |
|
|
HMHC
3320
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $3.26M | ﹤0.01% |
242,675
-101,106
| -29% | -$1.27M |
|
3321
Neuropace
NPCE
$439M
| $3.26M | ﹤0.01% |
205,446
-48,792
| -19% | -$1.02M |
|
|
IBER
3322
DELISTED
Ibere Pharmaceuticals
IBER
| $3.26M | ﹤0.01% |
335,990
+104,000
| +45% | +$1.01M |
|
|
SEEL
3323
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $3.25M | ﹤0.01% |
352
-137
| -28% | -$1.18M |
|
|
SBEA
3324
DELISTED
SilverBox Engaged Merger Corp I Class A Common Stock
SBEA
| $3.25M | ﹤0.01% |
332,335
-397,221
| -54% | -$3.86M |
|
3325
Revvity
RVTY
$12.6B
| $3.25M | ﹤0.01% |
18,750
-134,940
| -88% | -$23.8M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.